Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Robalzotan

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Robalzotan
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • (3R)-3-[di(cyclobutyl)amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC18H23FN2O2
Molar mass318.392 g·mol−1
3D model (JSmol)
  • C1CC(C1)N(C2CCC2)[C@@H]3CC4=C(C=CC(=C4OC3)F)C(=O)N
  • InChI=1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1 ☒N
  • Key:MQTUXRKNJYPMCG-CYBMUJFWSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Robalzotan (NAD-299,AZD-7371) is aselectiveantagonist at the5-HT1Areceptor.[1] It was shown to completely reverse theautoreceptor-mediated inhibition ofserotonin release induced by the administration ofselective serotonin reuptake inhibitors likecitalopram inrodent studies.[2] It was subsequently investigated byAstraZeneca as a potentialantidepressant but like many other 5-HT1A ligands was discontinued.[3] Later on it was researched for other indications such asirritable bowel syndrome but was dropped once again.[4]

See also

[edit]

References

[edit]
  1. ^Jerning E, Svantesson GT, Mohell N (1998). "Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist".Eur J Pharmacol.360 (2–3):219–225.doi:10.1016/S0014-2999(98)00667-0.PMID 9851589.
  2. ^Arborelius L, Wallsten C, Ahlenius S, Svensson TH (1999). "The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing".Eur J Pharmacol.382 (2):133–138.doi:10.1016/S0014-2999(99)00592-0.PMID 10528148.
  3. ^Mucke HA. (2000). "Robalzotan AstraZeneca".Curr Opin Investig Drugs.1 (2):236–240.PMID 11249580.
  4. ^Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG (October 2008). "Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome".The American Journal of Gastroenterology.103 (10):2562–9.doi:10.1111/j.1572-0241.2008.02115.x.PMID 18775020.
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Miscellaneous
5-HT1ARTooltip 5-HT1A receptoragonists
GABAARTooltip GABAA receptorPAMsTooltip positive allosteric modulators
Gabapentinoids
(α2δVDCCblockers)
Antidepressants
Sympatholytics
(Antiadrenergics)
Others
Drugs for
functional
bowel
disorders
Antimuscarinics
Tertiary
amino group
Quaternary
ammonium

compounds
Phosphodiesterase
inhibitors
Acting on
serotonin receptors
Other
Belladonna
and derivatives
(antimuscarinics)
Propulsives
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7


Stub icon

Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Robalzotan&oldid=1294256381"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp